Science as a Substitute for Geography
The Army’s High-Altitude Advantage—Altitude as a Strategic Asymmetry in Great-Power Competition
Karl E. Friedl, PhD
Lt. Col. Pierre A. Fabries, MD, PhD, French Armed Forces
Beth A. Beidleman, PhD
Download the PDF 
The next high-altitude conflict will not begin with maneuver—it will begin with hypoxia. Wars are not always decided by firepower. Sometimes they are decided by oxygen. During the Sino-Indian War in 1962, altitude incapacitated Indian units before decisive engagement occurred, demonstrating that thin air alone can erode combat power.1 The lesson did not fade; it hardened. Today, near-peer competitors sustain large forces above 14,000 feet along contested borders, where biology sets the tempo of operations.2
High altitude is not a niche environmental concern. It is a live operational variable in great-power competition. Along the Line of Actual Control, India and China maintain large formations in terrain where hypobaric hypoxia degrades work and cognitive capacity, disrupts sleep and disturbs mood state, increases nonbattle casualties, and slows operational tempo.3 For expeditionary forces, the first days at altitude are the most dangerous, when responsiveness and credibility matter most.
Afghanistan provides a contemporary validation of this lesson with major engagements occurring at Takur Ghar (10,500 feet) and Tora Bora (14,400 feet).4 The after action reports described units as “combat ineffective” by altitude illness, and during Operation Anaconda, nearly 15 percent of the casualties were treated for severe acute mountain sickness by one forward surgical team.5 Special operations forces fought in the Battle of Takur Ghar at over 3,000 meters (greater than 10,000 feet) in 2002, one of the highest military engagements in US history.6 The high altitude, cold temperature, and rugged terrain significantly impeded performance to the extent that “it would took four men in superb physical condition twenty minutes to move [an injured] man eighty meters.”7 In Operation Anaconda, some of the soldiers benefited from predosing with acetazolamide, a drug with Army-tested proven safety and efficacy in preventing symptoms of acute mountain sickness.8 At this elevation (10,000 feet), approximately 20 percent of unacclimatized individuals will experience physiological problems that can significantly impair performance, including acute mountain sickness with severe mental confusion, high-altitude pulmonary and cerebral edema (life-threatening conditions), retinal hemorrhage, and peripheral or facial swelling. The problems arise from predictable hypoxia under rapid insertion.
The Sino-Indian War previously exposed a strategic truth: altitude alone could determine readiness.9 Western planners realized they lacked doctrine for sustained land operations above 10,000 feet. Aviation medicine offered limited guidance, and alpine warfare experience was episodic. There was no institutional playbook for how soldiers live, work, think, and fight for weeks at 14,000 feet.
Turning Shock into Institutional Advantage
In the wake of the Himalayan conflict, the US Army made a deliberate decision: altitude would be measured, quantified, and engineered into doctrine. For the past fifty years, the US Army Research Institute of Environmental Medicine (USARIEM) has sustained a dedicated altitude research line of effort at Pikes Peak (14,300 feet above sea level) in Colorado, advancing the science from defining problems to developing countermeasures for health and performance at altitude.10
The first step in physiological research is the development of a metric for the problem, in this case, the development of the standardized Environmental Symptoms Questionnaire to quantify acute mountain sickness.11 Altitude illness moved from anecdote to data as commanders could track symptom burden, compare interventions, and manage ascent decisions with evidence rather than folklore. More recently, predictive physiological monitoring has advanced altitude management from reactive treatment to early identification of risk (i.e., the Altitude Readiness Management System).12
The second step was staging reform. Rapid ascent without acclimatization had proven catastrophic in the Himalayas. Controlled ascent studies at Pikes Peak quantified the relationship among altitude gain, time, exertion, and illness risk. Staging is the safest prevention as altitude illness is dose dependent.13 The Army reframed acclimatization as “hypoxic dose” (altitude multiplied by time and workload), transforming adaptation from passive waiting into a measurable planning variable.14 Predictive models of acute mountain sickness now allow commanders to estimate risk before movement begins.15
The third step addressed was sustained performance. Operational history suggested that strength, endurance, and cognitive clarity eroded progressively at altitude. Research at 14,300 feet demonstrated that energy deficit, sleep disruption, and cumulative fatigue, not oxygen alone, drive performance collapse.16 Quantitative modeling of sustained physical task performance showed that degradation follows predictable patterns under defined hypoxic exposure.17 Intermittent altitude exposure was evaluated as a predeployment countermeasure and shown to reduce acute mountain sickness under certain conditions.18 Performance loss is inevitable at altitude, but it is not random and not unknowable.
The Army also rejected customary remedies in favor of evidence. Acetazolamide was validated in controlled trials as an effective, medically approved countermeasure for acute mountain sickness.19 Other interventions such as blood doping did not provide advantage. Assumptions about who can tolerate altitude were tested. As such, fitness does not prevent acute mountain sickness and sex does not confer operational advantage, but genetic predisposition may play a role. Pharmacologic and intermittent hypoxic exposure interventions have also been evaluated, but acclimatization (or acclimation in artificial settings) remains the decisive factor.
High-altitude cerebral edema and pulmonary edema are relatively rare but lethal conditions in individuals who do not successfully adjust.20 Oxygen and medication help, but the definitive treatment is descent.21 This is a problem because evacuation slows in the mountains due to terrain and weather.
USARIEM has led scientific discoveries at altitude. It is the creation of this enduring scientific lane that prevents the Army from rediscovering altitude mid-conflict. This knowledge is retained in periodically updated military medical doctrine.22 India, China, and the United States have all confronted the same physiological constraint, but each built a different solution. India built safety through schedule, China built advantage through geography and infrastructure, and the US Army built advantage through science.
India: Protection Through Doctrine and Permanence
India’s experience in 1962 institutionalized altitude conservatism. Indian Armed Forces doctrine emphasizes tiered acclimatization, commonly structured in altitude bands above approximately 9,000 feet and include sleeping altitude control points.23 The designated overnight acclimatization staging elevations (“sleeping altitude control points”) are used by the Indian Army to regulate progressive ascent and reduce acute altitude illness risk. These permit the acclimatization process to occur especially during overnight residence, even if higher altitude was briefly reached during the day (a version of the “train high, sleep low” staging concept). These staging requirements are mandatory and time-based, designed to reduce acute mountain sickness, pulmonary edema, and nonbattle attrition.24 Recent guidance from the Indian Armed Forces Medical Services and the National Academy of Medical Sciences (India) task-force documents continues to prioritize structured staging and gradual ascent as the primary mitigation strategy.25 Large formations are also rotated at high-altitude bases. This model protects manpower for sustained deployments along the Line of Actual Control, but the trade-off is tempo. Conservative staging assumes time is available and favors permanence over maneuver.
China: Geography and Infrastructure as Force Multipliers
China’s approach begins with geography. The Tibetan Plateau ranges between roughly 12,000 and 15,000 feet, and five million civilians reside permanently at altitude.26 Genetic research has identified adaptive signals in hypoxia-related pathways, most notably EPAS1 variants in Tibetan populations, associated with distinctive physiological responses that provide an advantage at altitude.27 EPAS1 has been referred to as the “super athlete gene” because it encodes a master oxygen-sensing regulator (hypoxia inducible factor-2 alpha) that activates a wide range of adaptive responses in low oxygen environments. For example, a low oxygen environment can overstimulate red blood cell production in lowlanders; for Tibetans, the EPAS1 gene adaptation suppresses this response, preventing chronic mountain sickness caused by excessive red cell concentration.28 EPAS1 provides substantial physiological advantage to Tibetans, where cell-level oxygen sensing provides coordinated physiological responses that matter more to health and performance than bulk oxygen delivery alone.
The People’s Liberation Army supplements this biological baseline with infrastructure. Han Chinese do not have the Tibetan genetic adaptation and are provided with portable oxygen supply devices on the Tibetan plateau.29 Official Ministry of National Defense releases describe the expanded oxygen supply systems at posts above 10,000 feet, framing oxygen as readiness infrastructure rather than emergency medicine.30 China makes oxygen a logistics solution at scale, whereas US doctrine treats oxygen as effective but logistically prohibitive for individual soldiers in field operations.
China’s model reduces early exposure shock through residency and engineered mitigation. However, chronic high-altitude morbidity, including excessive red blood cell production, remains documented in plateau populations.31 Permanent exposure reduces surprise, but it does not eliminate physiological burden.
The US Army: Engineering a Substitute for Plateau
The US Army cannot replicate India’s garrison model or China’s plateau population reservoir as its forces are rotational and expeditionary. That constraint produced a strategic innovation: substitute scientific preparation for geography. Pikes Peak became a real-altitude laboratory where ascent rates, sleep disruption, workload, nutrition, countermeasures, and recovery could be studied under controlled conditions. Instead of assuming time for adaptation, the Army developed tools to predict risk. Instead of accepting performance collapse as inevitable, it identified controllable contributors such as energy deficit and sleep instability. Instead of relying on tradition, it validated pharmacologic intervention. As science evolves, new options continuously emerge for health and performance enhancement of soldiers in extreme environments. USARIEM research on Pikes Peak in 2026 involves a complex study with soldiers testing a newly approved drug that manipulates hypoxia inducible factor proteins, potentially compressing some aspects of altitude acclimatization into a rapid pharmacology strategy.
Why It Matters Now
High altitude remains a live theater. Border crises in recent years underscore that mountain conflict is contemporary. Expeditionary units are most vulnerable during the first seventy-two hours at altitude. In a crisis, those hours matter. The lesson is not confined to 1962. Since 1984, Indian and Pakistani forces have sustained deployments on the Siachen Glacier (often above 18,000 feet), where nonbattle casualties from cold injury, avalanche, and hypoxia historically exceeded combat losses.32 Altitude has repeatedly shaped readiness independent of maneuver. The pattern is consistent: thin air punishes unprepared forces.
The Army’s sustained investment in real-altitude research functions as a readiness hedge: It reduces nonbattle casualties, shortens time-to-effectiveness, provides commanders with evidence-based planning assumptions, and preserves maneuver flexibility. China manages altitude through residence and infrastructure, while India manages it through schedule, and the US Army through measurement, countermeasures, and prediction. That difference is strategic.
Conclusion: Never Again Surprised by Thin Air
The Sino-Indian War demonstrated that altitude can decide readiness before engagement begins. China invested in geography. India invested in schedule. The US Army invested in science. By sustaining real-altitude research at Pikes Peak, the Army ensured that thin air would never again be a strategic surprise. Altitude is not an act of God; it is a planning factor.
The views expressed in this manuscript reflect the results of research conducted by the authors and do not necessarily reflect the official policy or position of the US Army, Department of War, or the US government.
Notes 
- Neville Maxwell, India’s China War (Jonathan Cape, 1970).
- Niharika Mandhana et al., “Chinese Forces Battle Dizzying Altitudes to Expand Military Footprint,” Wall Street Journal, 5 December 2025, https://www.wsj.com/world/china/chinese-forces-battle-dizzying-altitudes-to-expand-military-footprint-c9350bbd; Dennis J. Blasko, “A Baseline Assessment of the PLA Army’s Border Reinforcement Operations in Aksai Chin in 2020 and 2021,” China Landpower Studies Center, 9 April 2024, https://ssi.armywarcollege.edu/SSI-Media/Recent-Publications/Display/Article/3735300/a-baseline-assessment-of-the-pla-armys-border-reinforcement-operations-in-the-a/; Ian Hall, “India 2024: Challenges and Contention in Foreign Policy,” Asia Maior 35 (2024): 315–34, https://www.asiamaior.org/?p=2326.
- Sun Xingwei and Wu Duoqi, “PLA Realizes Oxygen Supply at All Posts Above 3,000m,” Ministry of National Defense of the People’s Republic of China, 25 November 2020, http://eng.mod.gov.cn/xb/News_213114/TopStories/4874542.html; Y. S. Rajesh et al., “Study of Psychological Effects of Deployment at Extreme High Altitude on Soldiers,” Medical Journal Armed Forces India 77, no. 4 (2021): 426–30, https://doi.org/10.1016/j.mjafi.2020.06.002.
- George W. Rodway and Stephen R. Muza, “Fighting in Thin Air: Operational Wilderness Medicine in High Asia,” Wilderness & Environmental Medicine 22, no. 4 (2011): 297–303, https://doi.org/10.1016/j.wem.2011.08.009.
- George E. Peoples et al., “The 274th Forward Surgical Team Experience During Operation Enduring Freedom,” Military Medicine 170, no. 6 (2005): 451–59, https://doi.org/10.7205/milmed.170.6.451.
- Patrick Copeland, Alex Pytlar, and Chris Fuhrman, “The Battle of Takur Ghar: A Geographic Analysis,” Middle States Geographer 54 (2022): 67–76, https://msaag.aag.org/wp-content/uploads/2022/06/8-Copeland-et-al-MSG54-2021.pdf.
- Sean Naylor, Not a Good Day to Die: The Untold Story of Operation Anaconda (Penguin, 2005), 363.
- George S. Midla, “Lessons Learned: Operation Anaconda,” Military Medicine 169, no. 10 (2004): 810–13, https://doi.org/10.7205/milmed.169.10.810.
- Maxwell, China’s India War.
- Pierre A. Fabries et al., “Fifty Years of Army Research on Pikes Peak: Return on Investment,” manuscript in preparation, US Army Research Institute of Environmental Medicine, October 2026.
- Beth A. Beidleman et al., “Validation of a Shortened Electronic Version of the Environmental Symptoms Questionnaire,” High Altitude Medicine & Biology 8, no. 3 (2007): 192–99, https://doi.org/10.1089/ham.2007.1016.
- Beth Beidleman et al., “New Metric of Hypoxic Dose Predicts Altitude Acclimatization Status Following Various Ascent Profiles,” Physiological Reports 7, no. 20 (2019): e14263, https://doi.org/10.14814/phy2.14263.
- Pierre A. Fabries et al., “Active Ascent Accelerates the Onset of Acute Mountain Sickness at 4,300 m,” Journal of Applied Physiology 139, no. 2 (2025): 557–69, https://doi.org/10.1152/japplphysiol.00391.2025; Beth A. Beidleman et al., “Effect of Six Days of Staging on Physiologic Adjustments and Acute Mountain Sickness During Ascent to 4,300 Meters,” High Altitude Medicine & Biology 10, no. 3 (2009): 253–60, https://doi.org/10.1089/ham.2009.1004; Beidleman et al., “New Metric of Hypoxic Dose Predicts Altitude Acclimatization Status Following Various Ascent Profiles”; Beth A. Beidleman et al., “Predictive Models of Acute Mountain Sickness After Rapid Ascent to Various Altitudes,” Medicine & Science in Sports & Exercise 45, no. 4 (2013): 792–800, https://apps.dtic.mil/sti/tr/pdf/ADA575842.pdf.
- Beidleman et al., “New Metric of Hypoxic Dose Predicts Altitude Acclimatization Status Following Various Ascent Profiles.”
- Beidleman et al., “Predictive Models of Acute Mountain Sickness After Rapid Ascent to Various Altitudes.”
- Allan Cymerman and Peter B. Rock, Medical Problems in High Mountain Environments, USARIEM Technical Report 94-2 (US Army Research Institute of Environmental Medicine, 1994), https://apps.dtic.mil/sti/tr/pdf/ADA278095.pdf; John S. Edwards et al., Assessment of Nutritional Intake and Energy Expenditure of Unacclimatized U.S. Army Soldiers Living and Working at High Altitude, Technical Report T10-91 (US Army Research Institute of Environmental Medicine, 1991), https://apps.dtic.mil/sti/tr/pdf/ADA237450.pdf; Peter S. Figueiredo et al., “Acute Mountain Sickness and Sleep Disturbances Differentially Influence Cognition and Mood During Rapid Ascent to 3,000 and 4,050 m,” Physiological Reports 10, no. 3 (2022): e15175, https://doi.org/10.14814/phy2.15175.
- Beth A. Beidleman et al., “Quantitative Model of Sustained Physical Task Performance at Varying Altitudes,” Medicine & Science in Sports & Exercise 48 (2015): 323–30, https://doi.org/10.1249/mss.0000000000000768.
- Beth A. Beidleman et al., “Intermittent Altitude Exposures Reduce Acute Mountain Sickness at 4,300 m,” Clinical Science 106, no. 3 (2004): 321–28, https://doi.org/10.1042/cs20030161.
- Stanley A. Forwand et al., “Effect of Acetazolamide on Acute Mountain Sickness,” New England Journal of Medicine 279, no. 16 (1968): 839–45, https://www.doi.org/10.1056/NEJM196810172791601.
- Cymerman and Rock, Medical Problems in High Mountain Environments.
- Rodway and Muza, “Fighting in Thin Air”; Kyle McLaughlin et al., “Pharmacological Prophylaxis and Supplemental Oxygen for Unacclimatized Rescuers at Very High Altitude: Scoping Review and 2025 Joint Recommendations of the International Commission for Mountain Emergency Medicine and the International Society for Mountain Medicine,” High Altitude Medicine and Biology 27, no. 1 (2026): 60–67, https://journals.sagepub.com/doi/pdf/10.1177/15578682251365931.
- Headquarters, Department of the Army, Altitude Acclimatization and Illness Management, Technical Bulletin Medical 505 (Headquarters, Department of the Army, September 2010), https://usariem.health.mil/assets/docs/partnering/TB-Med-505-Sept-2010.pdf.
- V. Sabid Syed et al., “Determinants of Acclimatisation in High Altitude,” Medical Journal of the Armed Forces of India 66, no. 3 (2011): 261–65, https://doi.org/10.1016/S0377-1237(10)80052-8.
- Gaurav Sikri et al., “Is It Time to Revise the Acclimatization Schedule at High Altitude? Evidence from a Field Trial in the Western Himalayas,” Medical Journal Armed Forces India 75, no. 3 (2019): 251–58, https://doi.org/10.1016/j.mjafi.2018.01.001; Sandeep Thareja et al., “NAMS Task Force Report on High Altitude Illness,” Annals of the National Academy of Medical Sciences (India) 61, no. 1 (January-March 2025): 45–65, https://www.nams-annals.in/nams-task-force-report-on-high-altitude/ india.in/anams/2025/NAMS%20task%20force%20report%20on%20high%20altitude.pdf.
- Thareja et al., “NAMS Task Force Report on High Altitude Illness.”
- Tianyl Wu, “The Qinghai-Tibetan Plateau: How High Do Tibetans Live?,” High Altitude Medicine and Biology 2, no. 4 (2001): 489–99, https://doi.org/10.1089/152702901753397054.
- Cynthia M. Beall et al., “Natural Selection on EPAS1 (HIF2alpha) Associated with Low Hemoglobin Concentration in Tibetan Highlanders,” Science 329, no. 5987 (2010): 75–78, https://doi.org/10.1073/pnas.1002443107.
- Beall et al., “Natural Selection on EPAS1 (HIF2alpha) Associated with Low Hemoglobin Concentration in Tibetan Highlanders.”
- Jui-Lin Fan et al., “Differential Brain and Muscle Tissue Oxygenation Responses to Exercise in Tibetans Compared to Han Chinese,” Frontiers in Physiology 12 (2021): 617954, https://doi.org/10.3389/fphys.2021.617954.
- James A. Litch and Rachel A. Bishop, “Oxygen Concentrators for the Delivery of Supplemental Oxygen in Remote High-Altitude Areas,” Wilderness and Environmental Medicine 11 (2000): 189–91, https://doi.org/10.1580/1080-6032(2000)011[0189:ocftdo]2.3.co;2; Chao Guo et al., “Modulating Sleep at High Altitude: Experimental Effects of Multi-Gradient Oxygen Interventions on the Quinghai-Tibet Plateau,” Building and Environment 287, part B (2026): 113914, https://doi.org/10.1016/j.buildenv.2025.113914; Liu Xuanzun, “PLA Plateau Troops Get Portable Individual Oxygen Supply Devices for Soldiers,” Global Times, 31 October 2021, https://globaltimes.cn//author/Reporter-Liu-Xuanzun.html; Enoch Wong, “China Military Improves Air Supply for Troops at Himalayan Border with India,” South China Morning Post, 9 January 2025, https://www.scmp.com/news/china/military/article/3293846/china-military-improves-air-suppy-troops-himalayan-border-india; Ministry of National Defense of the People’s Republic of China, “China Upgrades Oxygen Supply Facilities for Border Troops in High-Altitude Tibet (Video),” China Military Online, 9 February 2021, http://eng.mod.gov.cn/xb/News_213114/Videos/4878887.html.
- Wu W. et al., “Elevated Red Cell Distribution Width Is an Indicator for Chronic Mountain Sickness in High Altitude Polycythemia Patients,” Respiratory Medicine (2025): 108588, https://doi.org/10.1016/j.rmed.2025.108588.
- Manoj Joshi, The Lost Rebellion: Kashmir in the Nineties (Penguin, 1999).
Karl E. Friedl, PhD, is a senior research scientist (SES/ST) in military environmental physiology. He served for thirty years as a senior uniformed Army research leader and has directed programs in operational medicine, human performance, and environmental stress. Friedl holds a PhD in physiology and has published extensively on limits of human performance, metabolic stress, and military readiness.
Lt. Col. Pierre A. Fabries, MD, PhD, is a French military physiologist and operational medicine officer specializing in aerospace and sports medicine. He served with the French Armed Forces in Dakar and Senegal, at the French Armed Forces Biomedical Research Institute in Brétigny-sur-Orge, and was deployed on operations in the Sahel. He is currently conducting altitude research at the US Army Research Institute of Environmental Medicine under the Engineer and Scientist Exchange Program. His work focuses on the impact of extreme environments, including hypoxia, high altitude, and aeronautical constraints, on soldiers’ health and performance.
Beth A. Beidleman, PhD, is a research physiologist at the US Army Research Institute of Environmental Medicine. Her work focuses on altitude acclimatization, hypoxic dose modeling, and countermeasures to preserve warfighter performance in extreme environments. She is the Army’s altitude physiology subject-matter expert and has conducted over twenty major field studies with soldiers at altitude.
Back to Top